GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Purchase Of Business

OncoTherapy Science (TSE:4564) Purchase Of Business : 円0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Purchase Of Business?

OncoTherapy Science's purchase of business for the three months ended in Sep. 2024 was 円0.0 Mil. It means OncoTherapy Science spent 円0.0 Mil on purchasing business. OncoTherapy Science's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.0 Mil.

Compared with last quarter (円0.0 Mil in Mar. 2024 ), OncoTherapy Science spent the same money on purchasing business in Sep. 2024 (円0.0 Mil).


OncoTherapy Science Purchase Of Business Historical Data

The historical data trend for OncoTherapy Science's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Purchase Of Business Chart

OncoTherapy Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoTherapy Science Purchase Of Business Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoTherapy Science Business Description

Traded in Other Exchanges
N/A
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines